5 completed, 1 unknown, 1 withdrawn. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 5, Unknown 1, Withdrawn 1 |
Follow Antibiotic Side Effect: new trials by email Literature Review of Antibiotic Side Effect trials Research Report on Antibiotic Side Effect
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention of Cefoperazone-induced Coagulopathy Vitamin K - Antibiotic Side Effect | Phase 4 | Completed | Helwan University | 56 | 2023-02-25 | 2023-10-10 |
| Individualized Duration of Antibiotic Treatment in Early Onset Infection in Newborns. Individualized treatment duration strategy - Early-Onset Neonatal Sepsis, Antibiotic Side Effect | Phase 4 | Completed | Ulrikka Nygaard | 488 | 2022-04-22 | 2026-01-12 |
| Use of Preoperative and Postoperative Antimicrobial Treatment Antibiotic - Ear Infection Bacterial, Surgical Site Infection | Phase 4 | Unknown | Sunnybrook Health Sciences Centre | 304 | 2021-06-01 | 2021-10-04 |
| Postoperative Antibiotics Following Primary and Secondary Breast Augmentation Cefazolin, Cephalexin, Placebo - Surgical Site Infection, Capsular Contracture Associated With Breast Implant | Phase 4 | Withdrawn | University of California, Los Angeles | 2021-04-01 | 2022-09-14 | |
| Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin Levofloxacin Ophthalmic, Moxifloxacin Ophthalmic - Cataract Senile, Endophthalmitis | Phase 4 | Completed | Peregrine Eye and Laser Institute | 114 | 2018-01-02 | 2020-05-27 |
| Topical Antibiotic Prophylaxis for Eyelids Topical Antibiotic Product, Topical Non-Antibiotic Ointment - Antibiotic Side Effect, Eyelid; Wound | Phase 4 | Completed | University of California, San Francisco | 401 | 2017-10-02 | 2020-07-21 |
| Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria Cotrimoxazole, Placebo - HIV-1-infection, Pneumocystis Pneumonia | Phase 4 | Completed | University of Bergen | 537 | 2017-03-30 | 2019-10-02 |
Surgical Wound Infection (3) · Endophthalmitis (1) · Eyelid Diseases (1) · Hemostatic Disorders (1) · Infections (1) · Neonatal Sepsis (1) · Opportunistic Infections (1) · Pneumonia, Pneumocystis (1) · Surgical Wound (1) · Wounds and Injuries (1)
Infections (5) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Postoperative Complications (3) · Wound Infection (3) · Eye Diseases (2) · Bacterial Infections and Mycoses (1) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Eye Infections (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Infant, Newborn, Diseases (1) · Inflammation (1)
Anti-Bacterial Agents (1) · Bacitracin (1) · Cefazolin (1) · Cephalexin (1) · Clindamycin (1) · Erythromycin (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1) · Vitamin K (1)
Helwan University (1) · Peregrine Eye and Laser Institute (1) · Sunnybrook Health Sciences Centre (1) · Ulrikka Nygaard (1) · University of Bergen (1) · University of California, Los Angeles (1) · University of California, San Francisco (1)
Canada (1) · Denmark (1) · Egypt (1) · Philippines (1) · Tanzania (1) · United States (1)
Emma Malchau Carlsen, MD, PhD (1) · Harvey S Uy, MD (1) · Jaco Festekjian, MD (1) · Joel Manyahi, MD (1) · Karie Villanueva, MD (1) · Robert Kersten, MD (1) · Tine Brink Henriksen, MD, Prof (1)